BACK TALK

Back Talk: Hail to the . . . CEO?

Back Talk: Is Cost Myopia Unfocused?

Before you fire up your outrage and vent your spleen, take a long look inside your parents' (or your own) medicine chest

Leadership and Truth

In Jack Welch's view, one of the worst mistakes a manager can make is . . .

Back Talk: In a Jam? Do the Right Thing

A textbook example of a firm doing the right thing in a crisis: J&J's decisive crisis management saved a brand

Who Will Pay the Piper?

Robbing pharma to pay Senator Pothole will not encourage innovation

Back Talk: Eyes up, I'm talking to you!

Your move? Lean in and make eye contact. Show that you care

Back Talk: Lonely at the top?

Being in charge does not mean that you need to make every decision

Phone-free connections?

At any well-run business meeting, a smartphone is not only disruptive but also signals that its user is less than fully engaged with the business at hand

Who's calling who "murky"?

Once we venerated doctors. Now we question every dollar they make

Give docs a shot in the arm

Is there anything that pharma can do to make doctors' lives easier?


Email Newsletters


Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.